Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization.
Alessandra
A
Serrao
Giuseppina
G
Loglisci
Adriano
A
Salaroli
Irene
I
Zacheo
Giuliana
G
Alimena
Massimo
M
Breccia
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000627:therapeutic use*; D001374:Azacitidine / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D023981:Sarcoma, Myeloid / Q000188:drug therapy / Q000532:radiotherapy; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine